Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
作者信息
Eckhardt S, Kerpel-Fronius S, Horváth I P, Institoris L
出版信息
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):783-8.
PMID:3985644
Abstract
摘要
相似文献
1
Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 2):783-8.
2
Complex evaluation of the effect of some cytostatic hexitol derivatives.某些细胞抑制性己糖醇衍生物效果的综合评估
Oncology. 1980;37 Suppl 1:104-8. doi: 10.1159/000225506.
3
Chemotherapeutic approaches to brain tumors. Experimental observations with dianhydrogalactitol and dibromodulcitol.
Cancer Chemother Pharmacol. 1982;8(1):125-31. doi: 10.1007/BF00292883.
4
Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
Cancer Treat Rep. 1983 Jul-Aug;67(7-8):737-8.
5
Hungarian anticancer drugs (antineoplastics).
Ther Hung. 1982;30(3):110-21.
6
Dianhydrogalactitol and neural tumors: an in vitro, in vivo preclinical evaluation.双脱水半乳糖醇与神经肿瘤：一项体外和体内临床前评估
Cancer Treat Rep. 1980;64(12):1287-94.
7
8
Effect of phenobarbital on the toxicity and antitumor activity of dibromodulcitol and dianhydrogalactitol.苯巴比妥对二溴卫矛醇和二去水半乳糖醇的毒性及抗肿瘤活性的影响。
Arzneimittelforschung. 1982;32(2):149-51.
9
10
Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Cancer Treat Rep. 1982 May;66(5):1231-2.
Zotero 插件